$60.0M
The London-based startup secured the capital to push its optical brain tracking technology toward hospitals and intensive care units.
AV
Angelini Ventures
Venture CapitalPortfolio
2
companies
Investment by month
By category
- Uncategorised£73.0M
- AI/ML£44.8M
By location
- Switzerland£73.0M
- London£44.8M
Portfolio companies
C
CoMind
Developing non-invasive optical technology to monitor brain activity and pressure without drilling into the skull.
N
Nuclidium
Nuclidium builds copper-based radiopharmaceuticals for precision cancer diagnosis and treatment.
Recent investments
€84.0M
The round was led by Kurma Growth Opportunities Fund, Angelini Ventures, Wellington Partners, and Neva SGR.